Founder & CEO of the Allele companies (Capital, Ventures, Communications) / Founder & Exec. Chairman Majesty Therapeutics / Board Member Praesidia Therapeutics
Fort Lauderdale, FL
Joined June 2013
- Tweets216
- Following710
- Followers208
- Likes608
Shawn Titcomb retweeted
Biotech Weekly Report – Week of March 21, 2025 ✅
Allele Capital's weekly report highlights the key developments across public markets, private financing, IPO activity, M&A, and strategic collaborations driving the industry forward and shaping the future of life sciences!
To receive our weekly report in your inbox, email us @ [email protected].
For more information & full disclosures, visit loom.ly/-n3ZxuM
#Biotech #LifeSciences #Investing #MergersAndAcquisitions #HealthcareInnovation
Shawn Titcomb retweeted
Dear President Biden:
Please address the American people explaining your position on chaos at Universities, war in Ukraine, war in Gaza and the US debt interest expense problem.
What are the available solutions? Which solutions will you pursue?
Sincerely,
Jeffrey Gundlach
Shawn Titcomb retweeted
BREAKING: Presidential candidate Vivek Ramaswamy has called for the
- removal of 75% of all government bureaucrats
- all agencies not authorized by Congress to be shut down
- term limits to be put in place.
Congratulations to our merchant portfolio company, $Coya, on their collaboration with $RDY for the development and commercialization of COYA 302 for #ALS, as well as Coya's concurrent $26.5M financing.
#tregs #ftd #Alzheimers $IBB $XBI
businesswire.com/news/home/2…
This should be eye-opening for many!
Presidents should be elected (or reelected) to lead for the good of their country and be judged on their policies and accomplishments, not by their personalities (whether you like them or dislike them).
NEW: Billionaire and Democrat voter Chamath Palihapitiya admits that he was wrong about President Trump and says he now "appreciates" what Trump was able to do.
Chamath also said Trump Derangement Syndrome did more damage than Trump ever did.
“The work on the border wall, we didn't like the messenger, so we killed the message. Turned out it was right.”
“Issuing long-term debt to refinance when rates were at zero. We didn't like the messenger, so we killed the message.”
“Peace in the Middle East. We didn't like the messenger, so we killed the message. When are we gonna stop shooting ourselves in the foot?”
Remarkable.
Shawn Titcomb retweeted
Your weekly report is available now!
Every week we go over the latest in Biotech news with our Biotech Weekly report
Read the full report here: loom.ly/XOFx8-c
#capitalmarkets #analytics #stocks #biotech #pharma #nasdaq #science #RandD #research
Shawn Titcomb retweeted
Stay up to date with the lates events in Biotech!
Every week we go over the latest in Biotech news with our Biotech Weekly report
Read the full report here: loom.ly/XOFx8-c
#capitalmarkets #analytics #stocks #biotech #pharma #nasdaq #science #RandD #research
Shawn Titcomb retweeted
Every week we go over the latest in Biotech news with our Biotech Weekly report
Read the full report here: loom.ly/XOFx8-c
#capitalmarkets #analytics #stocks #biotech #pharma #nasdaq #science #RandD #research
Shawn Titcomb retweeted
This weeks Biotech Weekly report is out! Read the full report here: loom.ly/XOFx8-c
#capitalmarkets #analytics #stocks #biotech #pharma #nasdaq #science #RandD #research
Shawn Titcomb retweeted
This weeks Biotech Weekly report is out! Read the full report here: loom.ly/XOFx8-c
#capitalmarkets #analytics #stocks #biotech #pharma #nasdaq #science #RandD #research
Shawn Titcomb retweeted
Dr. Stanley Appel, Coya Scientific Advisory Board Chair, details the role of Tregs in #neurodegenerative diseases & shares the exciting science behind Coya’s novel #Treg therapeutics currently in development for the treatment of #ALS & #Alzheimers bit.ly/3K6j7W4 $COYA
Shawn Titcomb retweeted
This weeks Biotech Weekly report is out! Read the full report here: loom.ly/XOFx8-c
#capitalmarkets #analytics #stocks #biotech #pharma #nasdaq #science #RandD #research
Shawn Titcomb retweeted
#Biomarker data presented at #AAIC23 showed a significant decrease in levels of the proinflammatory cytokines & chemokines CCL4, FLT3LG & TNFα in #Alzheimers patients treated with ld IL-2, strengthening Coya's previously announced positive results. bit.ly/3PY94WM $COYA
Shawn Titcomb retweeted
Coya reported additional #biomarker data from an open-label proof-of-concept clinical study for ld IL-2 in patients with #AlzheimersDisease during @alzassociation's #AAIC23. Learn more: bit.ly/3PY94WM $COYA
Shawn Titcomb retweeted
Check out 3 Allele clients on @BioPharmaDive most recent IPO's
Great to see Genelux standing out from the pack!
$GNLX $COYA $GDTC
#capitalmarkets #analytics #stocks #biotech #pharma #nasdaq #science
#RandD #research #biotech #biopharma
Shawn Titcomb retweeted
This weeks Biotech Weekly report is out! Read the full report here: loom.ly/XOFx8-c
#capitalmarkets #analytics #stocks #biotech
#pharma #nasdaq #science
#RandD #research
Shawn Titcomb retweeted
This weeks Biotech Weekly report is out! Read the full report here: loom.ly/XOFx8-c
#capitalmarkets #analytics #stocks #biotech
#pharma #nasdaq #science
#RandD #research
Shawn Titcomb retweeted
This weeks Biotech Weekly report is out! We are pleased to see our client @Genelux_Corp as the top performing Biotech IPO so far this year.
read the full report here loom.ly/XOFx8-c
#capitalmarkets #analytics #stocks #biotech
#pharma #nasdaq #science
#RandD #research
Shawn Titcomb retweeted
Allele Capital was recently part of an article on Investors.com @IBDinvestors Read the article here: loom.ly/ZoDLDFQ
Shawn Titcomb retweeted
Coya has released a letter to stockholders from its Chief Executive Officer and Chairman, Dr. Howard Berman. Read it here: bit.ly/3Xhh4E9 $COYA
